Does increased aromatase activity in adipose fibroblasts cause low sexual desire in patients with HIV lipodystrophy?
Authors:
- G ScullardGSG Scullard
- M KapembwaMKM Kapembwa
- H LambaHLH Lamba
- G FrizeGFG Frize
Open Access
- 1 February 2002
- journal article
- review article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 78 (1) , 64-66
Abstract
There is evidence from our own unit and other workers that many patients who have lipodystrophy on HAART given for HIV disease also have raised oestrogen levels and complain of low sexual desire. This hypothesis paper discusses a possible pathological mechanism for these changes—an increase in the number of fibroblasts and macrophages present in lipoatrophic areas that could convert testosterone to oestrogen by intracellular aromatisation. This process is known to be enhanced by increased levels of tumour necrosis factor, interleukin 6 (IL-6), and hydroxycorticosteroids present in many patients with HIV lipodystrophy. Treatment options are discussed, including aromatase inhibitors and testosterone.Keywords
This publication has 34 references indexed in Scilit:
- Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort studyThe Lancet, 2001
- Mechanisms of resistance of normal cells to TRAIL induced apoptosis vary between different cell typesFEBS Letters, 2000
- Autonomic neuropathy in patients with HIV: Course, impact of disease stage, and medicationClinical Autonomic Research, 2000
- Sexual dysfunction with protease inhibitorsThe Lancet, 1999
- Sexual dysfunction with protease inhibitorsThe Lancet, 1999
- Endocrine disorders associated with inappropriately high aromatase expressionThe Journal of Steroid Biochemistry and Molecular Biology, 1997
- Relations between sex hormone levels and sexual behavior in menArchives of Sexual Behavior, 1986
- Inhibition of sexual behavior by dopamine antagonist or serotonin agonist drugs in castrated male rats given estradiol or dihydrotestosteronePharmacology Biochemistry and Behavior, 1980
- Steroid abnormalities in endometrial and breast carcinoma: A unifying hypothesisJournal of Steroid Biochemistry, 1976
- EVIDENCE FOR HYPERŒSTROGENÆMIA AS A RISK FACTOR FOR MYOCARDIAL INFARCTION IN MENThe Lancet, 1976